Wang J and Ueda N |
Biology of endocannabinoid synthesis system. |
2009 |
Prostaglandins Other Lipid Mediat. |
pmid:19126434
|
Vignali M et al. |
The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes. |
2009 |
Glia |
pmid:19031444
|
Straiker A and Mackie K |
Cannabinoid signaling in inhibitory autaptic hippocampal neurons. |
2009 |
Neuroscience |
pmid:19501632
|
Yates ML and Barker EL |
Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. |
2009 |
Mol. Pharmacol. |
pmid:19389920
|
Hill MN et al. |
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. |
2009 |
Psychoneuroendocrinology |
pmid:19394765
|
Bajo M et al. |
Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. |
2009 |
J. Neurosci. Res. |
pmid:18816788
|
Bisogno T et al. |
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. |
2009 |
Biochim. Biophys. Acta |
pmid:19027877
|
Long JZ et al. |
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. |
2009 |
Nat. Chem. Biol. |
pmid:19029917
|
Schlosburg JE et al. |
Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. |
2009 |
AAPS J |
pmid:19184452
|
Koppel J et al. |
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study. |
2009 |
Lipids Health Dis |
pmid:19144193
|
Nyilas R et al. |
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. |
2009 |
Eur. J. Neurosci. |
pmid:19453631
|
Garcia-Ovejero D et al. |
The endocannabinoid system is modulated in response to spinal cord injury in rats. |
2009 |
Neurobiol. Dis. |
pmid:18930143
|
Wakley AA and Rasmussen EB |
Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats. |
2009 |
Pharmacol. Biochem. Behav. |
pmid:19602424
|
Izzo AA et al. |
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. |
2009 |
Br. J. Pharmacol. |
pmid:19371345
|
Catani MV et al. |
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol. |
2009 |
J. Mol. Med. |
pmid:18820887
|
Jiang LS et al. |
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. |
2009 |
Cardiovasc. Res. |
pmid:19074161
|
Avraham Y et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. |
2008 Jul-Aug |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:18771906
|
Hill MN et al. |
Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. |
2008 |
Hippocampus |
pmid:18058925
|
Maccarrone M et al. |
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. |
2008 |
Nat. Neurosci. |
pmid:18204441
|
Hashimotodani Y et al. |
Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. |
2008 |
Neuropharmacology |
pmid:17655882
|
Mátyás F et al. |
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
2008 |
Neuropharmacology |
pmid:17655884
|
Starowicz KM et al. |
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. |
2008 |
Obesity (Silver Spring) |
pmid:18239598
|
Shimizu T and Yokotani K |
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats. |
2008 |
Eur. J. Pharmacol. |
pmid:18234185
|
Moreira FA et al. |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. |
2008 |
Neuropharmacology |
pmid:17709120
|
Tam J et al. |
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. |
2008 |
FASEB J. |
pmid:17704191
|
Chiu CQ and Castillo PE |
Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus. |
2008 |
Neuropharmacology |
pmid:17706254
|
Vellani V et al. |
Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. |
2008 |
Neuropharmacology |
pmid:18329052
|
Engeli S et al. |
Peripheral endocannabinoid system activity in patients treated with sibutramine. |
2008 |
Obesity (Silver Spring) |
pmid:18356837
|
Guindon J and Hohmann AG |
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism. |
2008 |
Br. J. Pharmacol. |
pmid:18297102
|
Oláh M et al. |
The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG. |
2008 |
Mol. Cell. Endocrinol. |
pmid:18308464
|
Hu SS et al. |
Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. |
2008 |
Br. J. Pharmacol. |
pmid:18297109
|
Hill MN et al. |
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. |
2008 |
Pharmacopsychiatry |
pmid:18311684
|
Palkovits M et al. |
Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. |
2008 |
Neuroscience |
pmid:18343585
|
Nomura DK et al. |
Activation of the endocannabinoid system by organophosphorus nerve agents. |
2008 |
Nat. Chem. Biol. |
pmid:18438404
|
Bisogno T |
Endogenous cannabinoids: structure and metabolism. |
2008 |
J. Neuroendocrinol. |
pmid:18426492
|
Rubio M et al. |
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. |
2008 |
Neuropharmacology |
pmid:18371990
|
Di Marzo V and Maccarrone M |
FAAH and anandamide: is 2-AG really the odd one out? |
2008 |
Trends Pharmacol. Sci. |
pmid:18394720
|
Solinas M et al. |
The endocannabinoid system in brain reward processes. |
2008 |
Br. J. Pharmacol. |
pmid:18414385
|
Richardson D et al. |
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. |
2008 |
Arthritis Res. Ther. |
pmid:18416822
|
Palmer JA et al. |
Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. |
2008 |
Neuroscience |
pmid:18541380
|
Di Marzo V |
Endocannabinoids: synthesis and degradation. |
2008 |
Rev. Physiol. Biochem. Pharmacol. |
pmid:18481028
|
Pertwee RG |
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. |
2008 |
Addict Biol |
pmid:18482430
|
Di Filippo M et al. |
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. |
2008 |
J. Neurol. Neurosurg. Psychiatr. |
pmid:18535023
|
Awumey EM et al. |
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18375719
|
Ellgren M et al. |
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. |
2008 |
Eur Neuropsychopharmacol |
pmid:18674887
|
Placzek EA et al. |
Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. |
2008 |
J. Neurochem. |
pmid:18778304
|
Placzek EA et al. |
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. |
2008 |
Neuropharmacology |
pmid:18760289
|
Qin N et al. |
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. |
2008 |
J. Neurosci. |
pmid:18550765
|
Muccioli GG and Stella N |
An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. |
2008 |
Anal. Biochem. |
pmid:17981259
|
Thiemann G et al. |
The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. |
2008 |
Behav. Brain Res. |
pmid:17988751
|